Medicare prices are rising in 2026, but savvy seniors can save during open enrollment (and beyond) with these cost-cutting ...
Barchart on MSN
Are Wall Street Analysts Bullish on Elevance Health Stock?
With a market cap of $72.1 billion, Elevance Health, Inc. (ELV) is one of the largest health insurance and managed care ...
17hon MSN
Should You Invest in Humana (HUM)?
Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter 2025 investor letter. A ...
The founder and a former top doctor at Done Global were convicted by a San Francisco jury of conspiring to distribute Adderall and other stimulants, in the first federal prosecution of alleged illegal ...
Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc. (SCCM), has released its ...
Several high-ranking Army officials, including Army Secretary Dan Driscoll, are in Ukraine to help with peace talks, U.S.
Though healthcare stocks have been much more measured this year, there are bright spots there as well. The medical-device maker Medtronic (MDT) closed at its highest price since May 12, 2022, after ...
When Donald Trump won the presidency last year, geopolitical experts predicted a cozy U.S. relationship with India, a major global economy and the world’s largest democracy. The Trump administration ...
Trump’s authoritarian corruption thrives on making clear that the path of least resistance is to bend the knee and pay off ...
The importance of planning for the possibility of living to 100 has never been greater. Although the average American lifespan is now around 79, the chances of reaching 100 have grown dramatically in ...
MarketBeat on MSN
Healthcare Rotation Underway: 3 Stocks Leading the Charge
Is the artificial intelligence revolution hitting its first roadblock? For the first time since the AI boom began in 2023, ...
Does Foghorn Therapeutics (FHTX) Have the Potential to Rally 133.27% as Wall Street Analysts Expect?
The mean of analysts' price targets for Foghorn Therapeutics (FHTX) points to a 133.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results